regulatory capture
The United States: An Exceptional Case? A Webinar With Stephen Haber, Richard R. John, and Luigi Zingales
Many see the US as a land where free markets and antitrust enforcement have historically kept monopolies under control. But is that really the...
A New Stigler Center Case Study Explores the Link Between Italy’s Morandi Bridge Disaster and Crony Capitalism
Two years ago, the Morandi bridge collapse claimed 43 lives. Based on financial statements, Italian government documents, and interviews with independent experts and corporate...
Few Bad Apples? New Study Finds That 40 Percent of Officers in a Large Police Force Are Discriminatory
A new paper seeks to examine whether police misbehavior is concentrated or diffuse by identifying whether highway patrol officers in Florida are more lenient...
When Scholarship Turns Into Business: Stefano Feltri Responds to Paul Milgrom
Stefano Feltri responds to Paul Milgrom’s criticisms of his recent ProMarket piece on the 2017 FCC spectrum auction.
In his response, Paul Milgrom discloses some...
Should We Leave Public Resource Allocation to the Experts? Glen Weyl Responds to Paul Milgrom
Glen Weyl, Microsoft’s Office of the Chief Technology Officer Political Economist and Social Technologist, responds to Paul Milgrom’s criticisms of his recent ProMarket piece...
Was the 2017 FCC Spectrum Auction a Success—or a Disappointing Failure?
In a post published on his company’s website, Stanford professor Paul Milgrom responded to the recent ProMarket pieces by Glen Weyl and Stefano Feltri...
Break Up the Police
In most cities in America, it is not the police that answers to the mayors, but the mayors to the police. The only solution...
AT&T’s Treatment of HBO Max Sparks Calls for Net Neutrality Rules. But Is Sector-Specific Regulation the Right Solution?
Not all forms of self-preferencing should be banned, but we do need a standard by which to evaluate allegations of anticompetitive self-preferencing. Congress should...
Are We Witnessing the Fall of the American Liberal Order?
In the past 30 years, liberalism has not lived up to its promise to deliver economic returns for the broad majority of society. But...
Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be
New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones.
Economists love health care because it...
